GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Island Pharmaceuticals ILA.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.33

0.00%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in AUD, from our data supplier.

FY2025

Revenue

A$58,800

FY2020FY2025

Net income

−A$3.9m

FY2020FY2025

Free cash flow

−A$2.8m

FY2020FY2025

Shareholders' equity

A$7.2m

FY2020FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
RevenueA$58,800A$4,700A$11,100———
Research and developmentA$1.4mA$2.3mA$1.1mA$1.0mA$2,600—
Operating income−A$3.9m−A$2.9m−A$2.9m−A$2.8m−A$2.1m−A$700
Net income−A$3.9m−A$2.9m−A$2.8m−A$2.6m−A$2.1m−A$700
Diluted earnings per share-0.02-0.03-0.03-0.03-0.02—

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Total assetsA$7.5mA$2.6mA$2.0mA$4.9mA$6.6m—
Cash and short-term investmentsA$7.3mA$1.7mA$2.0mA$4.8mA$6.5m—
Total liabilitiesA$336,400A$1.0mA$263,800A$580,700A$236,800A$700
Debt—A$422,000————
Shareholders' equityA$7.2mA$1.5mA$1.8mA$4.3mA$6.4m−A$700
Shares outstanding173m90m91m91m91m81m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations−A$2.8m−A$3.2m−A$2.7m−A$1.9m−A$938,200—
Free cash flow−A$2.8m−A$3.2m−A$2.7m−A$1.9m−A$938,200—

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
RevenueA$58,500A$300A$1,000A$3,800A$6,500A$4,600——
Operating income−A$2.4m−A$1.5m−A$1.7m−A$1.2m−A$1.3m−A$1.6m−A$1.9m−A$934,800
Net income−A$2.4m−A$1.5m−A$1.7m−A$1.2m−A$1.2m−A$1.6m−A$1.8m−A$846,000
Diluted earnings per share-0.01-0.01-0.02-0.01-0.01-0.02-0.02-0.01
Total assetsA$7.5mA$4.3mA$2.6mA$1.8mA$2.0mA$3.6mA$4.9mA$5.9m
Cash and short-term investmentsA$7.3mA$4.0mA$1.7mA$976,100A$2.0mA$3.4mA$4.8mA$5.8m
Shareholders' equityA$7.2mA$3.9mA$1.5mA$637,800A$1.8mA$2.9mA$4.3mA$5.8m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income11.5%461.2%—
Net income14.6%461.9%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-10638.3%———
Net margin-10684.1%———

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-19.0-5.4-3.1-6.5-10.9

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.